The Antiretroviral Nelfinavir Mesylate, a Potential Therapy for Systemic Scleroderma
Arthritis and Rheumatology - United Kingdom
doi 10.1002/art.40326
Full Text
Open PDFAbstract
Available in full text
Date
December 8, 2017
Authors
Publisher
Wiley
Available in full text
December 8, 2017
Wiley